학술논문
First-in-human study of naporafenib (LXH254) with or without spartalizumab in adult patients with advanced solid tumors harboring MAPK signaling pathway alterations
Document Type
Article
Author
Source
In: European Journal of Cancer . (European Journal of Cancer, January 2024, 196)
Subject
Language
English
ISSN
18790852
09598049
09598049